Literature DB >> 21436282

An ENU-induced mutation in the Mertk gene (Mertknmf12) leads to a slow form of retinal degeneration.

Dennis M Maddox1, Wanda L Hicks, Douglas Vollrath, Matthew M LaVail, Jürgen K Naggert, Patsy M Nishina.   

Abstract

PURPOSE: To determine the basis and to characterize the phenotype of a chemically induced mutation in a mouse model of retinal degeneration.
METHODS: Screening by indirect ophthalmoscopy identified a line of N-ethyl-N-nitrosourea (ENU) mutagenized mice demonstrating retinal patches. Longitudinal studies of retinal histologic sections showed photoreceptors in the peripheral retina undergoing slow, progressive degeneration. The mutation was named neuroscience mutagenesis facility 12 (nmf12), and mapping localized the critical region to Chromosome 2.
RESULTS: Sequencing of nmf12 DNA revealed a point mutation in the c-mer tyrosine kinase gene, designated Mertk(nmf12). We detected elevated levels of tumor necrosis factor (Tnf, previously Tnfa) in retinas of Mertk(nmf12) homozygotes relative to wild-type controls and investigated whether the increase of TNF, an inflammatory cytokine produced by macrophages/monocytes that signals intracellularly to cause necrosis or apoptosis, could underlie the retinal degeneration observed in Mertk(nmf12) homozygotes. Mertk(nmf12) homozygous mice were mated to mice lacking the entire Tnf gene and partial coding sequences of the Lta (Tnfb) and Ltb (Tnfc) genes.(2) B6.129P2-Ltb/Tnf/Lta(tm1Dvk)/J homozygotes did not exhibit a retinal degeneration phenotype and will, hereafter, be referred to as Tnfabc(-/-) mice. Surprisingly, mice homozygous for both the Mertk(nmf12) and the Ltb/Tnf/Lta(tm1Dvk) allele (Tnfabc(-/-)) demonstrated an increase in the rate of retinal degeneration.
CONCLUSIONS: These findings illustrate that a mutation in the Mertk gene leads to a significantly slower progressive retinal degeneration compared with other alleles of Mertk. These results demonstrate that TNF family members play a role in protecting photoreceptors of Mertk(nmf12) homozygotes from cell death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436282      PMCID: PMC3175976          DOI: 10.1167/iovs.10-7077

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  33 in total

1.  The mutation spectrum of the bestrophin protein--functional implications.

Authors:  B Bakall; T Marknell; S Ingvast; M J Koisti; O Sandgren; W Li; A A Bergen; S Andreasson; T Rosenberg; K Petrukhin; C Wadelius
Journal:  Hum Genet       Date:  1999-05       Impact factor: 4.132

2.  Optic neuropathy in refractory neurosarcoidosis treated with TNF-alpha antagonist.

Authors:  Batoul Salama; Jean-Jacques Gicquel; Patrice Lenoble; Paul Louis Dighiero
Journal:  Can J Ophthalmol       Date:  2006-12       Impact factor: 1.882

3.  Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro.

Authors:  C P Hamel; E Tsilou; B A Pfeffer; J J Hooks; B Detrick; T M Redmond
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

4.  Mertk triggers uptake of photoreceptor outer segments during phagocytosis by cultured retinal pigment epithelial cells.

Authors:  Wei Feng; Douglas Yasumura; Michael T Matthes; Matthew M LaVail; Douglas Vollrath
Journal:  J Biol Chem       Date:  2002-02-22       Impact factor: 5.157

5.  Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat.

Authors:  P M D'Cruz; D Yasumura; J Weir; M T Matthes; H Abderrahim; M M LaVail; D Vollrath
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

6.  Phagocytosis and clearance of apoptotic cells is mediated by MER.

Authors:  R S Scott; E J McMahon; S M Pop; E A Reap; R Caricchio; P L Cohen; H S Earp; G K Matsushima
Journal:  Nature       Date:  2001-05-10       Impact factor: 49.962

Review 7.  The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU).

Authors:  Andrew D Dick; John V Forrester; Janet Liversidge; Andrew P Cope
Journal:  Prog Retin Eye Res       Date:  2004-11       Impact factor: 21.198

8.  Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration.

Authors:  Panagiotis G Theodossiadis; Vasilios S Liarakos; Petros P Sfikakis; Ioannis A Vergados; George P Theodossiadis
Journal:  Am J Ophthalmol       Date:  2009-02-10       Impact factor: 5.258

9.  MERTK arginine-844-cysteine in a patient with severe rod-cone dystrophy: loss of mutant protein function in transfected cells.

Authors:  Christina L McHenry; Yuhui Liu; Wei Feng; Anita R Nair; Kecia L Feathers; Xiaoling Ding; Andreas Gal; Douglas Vollrath; Paul A Sieving; Debra A Thompson
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-05       Impact factor: 4.799

10.  Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales disease.

Authors:  Sandeep Saxena; Aditya B Pant; Vinay K Khanna; A K Agarwal; Kamlesh Singh; Dipak Kumar; Vijay K Singh
Journal:  Ocul Immunol Inflamm       Date:  2009 May-Jun       Impact factor: 3.070

View more
  5 in total

1.  Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma.

Authors:  Takehiko Shibata; David M Habiel; Ana L Coelho; Steven L Kunkel; Nicholas W Lukacs; Cory M Hogaboam
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

2.  Bisretinoids mediate light sensitivity resulting in photoreceptor cell degeneration in mice lacking the receptor tyrosine kinase Mer.

Authors:  Jin Zhao; Keiko Ueda; Marina Riera; Hye Jin Kim; Janet R Sparrow
Journal:  J Biol Chem       Date:  2018-10-23       Impact factor: 5.157

3.  Tyro3 Modulates Mertk-Associated Retinal Degeneration.

Authors:  Douglas Vollrath; Douglas Yasumura; Gillie Benchorin; Michael T Matthes; Wei Feng; Natalie M Nguyen; Cecilia D Sedano; Melissa A Calton; Matthew M LaVail
Journal:  PLoS Genet       Date:  2015-12-11       Impact factor: 5.917

4.  The tyrosine kinase receptor Tyro3 enhances lifespan and neuropeptide Y (Npy) neuron survival in the mouse anorexia (anx) mutation.

Authors:  Dennis Y Kim; Joanna Yu; Ryan K Mui; Rieko Niibori; Hamza Bin Taufique; Rukhsana Aslam; John W Semple; Sabine P Cordes
Journal:  Dis Model Mech       Date:  2017-01-12       Impact factor: 5.758

5.  Tissue-specific modifier alleles determine Mertk loss-of-function traits.

Authors:  Yemsratch T Akalu; Maria E Mercau; Marleen Ansems; Lindsey D Hughes; James Nevin; Emily J Alberto; Xinran N Liu; Li-Zhen He; Diego Alvarado; Tibor Keler; Yong Kong; William M Philbrick; Marcus Bosenberg; Silvia C Finnemann; Antonio Iavarone; Anna Lasorella; Carla V Rothlin; Sourav Ghosh
Journal:  Elife       Date:  2022-08-15       Impact factor: 8.713

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.